论文部分内容阅读
作者研究了12例难治性急性淋巴细胞白血病(ALL),此前均经过强烈的初期化疗及对初、复治耐药或复发,其中第1次复发2例,第2、3次复发各1例,其余8例对第1-4次复发时所给再诱导疗法均无效.该组不包括以往应用阿克拉霉素(ACA)或鬼臼乙叉甙
The authors studied 12 patients with refractory acute lymphoblastic leukemia (ALL) who had undergone strong initial chemotherapy and had resistance to relapse or retreatment. The first relapse occurred in 2 patients, and the second and third relapse were each 1 In other cases, the remaining 8 cases did not respond to the reinduction therapy given at the time of the 1-4 recurrence. This group did not include the former application of aclacinomycin (ACA) or etoposide.